Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Xuexin Cheng"'
Autor:
Jinfeng Zhu, Qian Huang, Xingyu Peng, Chen Luo, Zitao Liu, Dongdong Liu, Huazhao Yuan, Rongfa Yuan, Xuexin Cheng
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundPrevious studies have demonstrated that PANoptosis is strongly correlated with cancer immunity and progression. This study aimed to develop a PANoptosis-related signature (PANRS) to explore its potential value in predicting the prognosis an
Externí odkaz:
https://doaj.org/article/97760b003b694eb588ee7ca06de80473
Autor:
Jianmo Liu, Yifan Wu, Weijie Jia, Mengqi Han, Yongsen Chen, Jingyi Li, Bin Wu, Shujuan Yin, Xiaolin Zhang, Jibiao Chen, Pengfei Yu, Haowen Luo, Jianglong Tu, Fan Zhou, Xuexin Cheng, Yingping Yi
Publikováno v:
Frontiers in Neuroscience, Vol 17 (2023)
PurposeThis study aimed to investigate the value of a machine learning-based magnetic resonance imaging (MRI) radiomics model in predicting the risk of recurrence within 1 year following an acute ischemic stroke (AIS).MethodsThe MRI and clinical data
Externí odkaz:
https://doaj.org/article/3e08353e1e7a40b387215e45e6c7ced5
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract This retrospective study aimed to explore the relative efficacy and safety of different tacrolimus (TAC) concentrations in the treatment of patients with idiopathic membranous nephropathy (IMN). A total of 260 IMN patients with nephrotic syn
Externí odkaz:
https://doaj.org/article/1e73ef2d075e4fcd9c8b55f89cf0977b
Autor:
Jinfeng Zhu, Qian Huang, Xingyu Peng, Chen Luo, Zitao Liu, Dongdong Liu, Huazhao Yuan, Rongfa Yuan, Xuexin Cheng
Publikováno v:
Frontiers in Immunology; 2023, p1-19, 19p
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports
Scientific Reports
This retrospective study aimed to explore the relative efficacy and safety of different tacrolimus (TAC) concentrations in the treatment of patients with idiopathic membranous nephropathy (IMN). A total of 260 IMN patients with nephrotic syndrome (NS
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
European Journal of Pharmacology. 907:174288
Chronic kidney disease (CKD) is an irreversible, progressive disease characterized by persistent kidney damage, and significantly increased risks of cardiovascular event. However, therapeutic strategies to prevent or slow the progression of CKD remai
Autor:
Jian Lu, Chao Li, Rena Boerhan, Xuexin Cheng, Qianxiong Zhou, Weize Sun, Na Tian, Xuesong Wang, Youchao Wang
Publikováno v:
Dalton transactions (Cambridge, England : 2003). 48(32)
Ru(ii) polypyridine complexes which can undergo photo-induced ligand dissociation and subsequent DNA covalent binding may potentially serve as photoactivated chemotherapeutic (PACT) agents. In this paper, three fluorinated dppz ligand coordinated Ru(
Autor:
Yuanjun Hou, Yue Zheng, Xuesong Wang, Xuexin Cheng, Yangyang Zhang, Weibo Wang, Qianxiong Zhou, Guoyu Jiang, T. Wang
Publikováno v:
RSC Advances. 6:45652-45659
Photoactivated chemotherapy (PACT) and photodynamic therapy (PDT) are two types of cancer treatment modalities that rely on photoinduced ligand dissociation and photosensitized or photocatalyzed reactive oxygen species (ROS) generation to realize ant
Publikováno v:
Dalton Transactions. 44:12726-12734
BODIPY (boron dipyrromethene) derivatives and Ru(ii) complexes are two types of functional compounds that have found wide applications in the fields of biology and medicine. We herein synthesized two new Ru(ii) arene complexes based on an iodized BOD